APYX — Apyx Medical Corp
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 719135 ·
Last close
$3.08
Market Cap
$129.74M
52W High
$5.08
52W Low
$2.89
ADV30
102,166
Next earnings
2026-11-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 13,884,000 | 8,870,000 | -1,806,000 | -3,243,000 | 61,072,000 | 27,617,000 | 49,982,000 |
| Mar 2026 | 12,490,000 | 7,925,000 | -911,000 | -2,108,000 | 63,025,000 | 31,137,000 | 49,937,000 |
| Dec 2025 | 19,164,000 | 11,999,000 | 11,000 | -1,299,000 | 66,840,000 | 31,740,000 | 52,009,000 |
| Sep 2025 | 12,877,000 | 8,297,000 | -832,000 | -1,984,000 | 57,365,000 | 25,135,000 | 51,285,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-7,871,000
Investing CF
$-1,119,000
Financing CF
$9,638,000
CapEx
$-1,119,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.22
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-94,473,000
Inventory
$10,747,000
Receivables
$13,614,000
ST Investments
—
EBIT TTM
$-2,388,000
Pretax Income TTM
$-7,971,000
Interest Exp TTM
$5,583,000
Analysts
5
Yahoo Snapshot (yfinance, live)
Total Revenue
$58,415,000
EBITDA
$-2,755,000
Free Cash Flow
$-9,631,625
Enterprise Value
$142,181,984
Total Cash
$27,617,000
Total Debt
$39,630,000
Shares Out
42,124,023
Trailing EPS
$-0.20
Book Value
$0.25
ROE
-90.7%
ROA
-3.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 52,844,000 | -6,446,000 | -11,211,000 | 66,840,000 | 52,009,000 | — | -8,001,000 |
| Dec 2024 | 48,102,000 | -18,845,000 | -23,463,000 | 64,842,000 | 50,507,000 | — | -18,047,000 |
| Dec 2023 | 52,349,000 | -19,951,000 | -18,713,000 | 79,240,000 | 52,318,000 | — | -5,249,000 |
| Dec 2022 | 44,510,000 | -23,562,000 | -23,184,000 | 51,775,000 | 13,982,000 | — | -20,280,000 |
TTM Snapshot
Revenues TTM
$41,468,000
NetIncome TTM
$-14,708,000
OpCashFlow TTM
$0
Assets (Latest)
$79,240,000
Forward EPS
$-0.26
Max Pain — expiry 2027-12-17
max pain strike: $2.50 · spot: $3.08 · call oi: 3,004 · put oi: 12
Expected Move to 2027-12-17:
±$2.86
(92.86%) —
implied range
$0.22 –
$5.94
· ATM straddle on $2.50 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| VANI | Vivani Medical, Inc. | $124.48M | $1.38 | — |
| GUTS | FRACTYL HEALTH, INC. | $119.38M | $0.75 | — |
| STXS | Stereotaxis, Inc. | $142.29M | $1.42 | — |
| INGN | Inogen Inc | $145.96M | $5.50 | — |
| LNSR | LENSAR, Inc. | $113.40M | $9.23 | — |
News headlines (Yahoo Finance, 1h cache)
Apyx Medical (APYX) Q2 2026 Earnings Call Transcript
2026-08-14 00:13 · Yahoo
Apyx Medical Sees GLP-1 Boom Fueling Demand for Renuvion, AYON Body Contouring
2026-08-12 00:04 · Yahoo
Apyx Medical Corp (APYX) (Q2 2026) Earnings Call Highlights: Revenue Surges 22% on Power Lipo ...
2026-08-07 05:11 · Yahoo
Apyx Medical (APYX) Reports Q2 Loss, Beats Revenue Estimates
2026-08-06 23:10 · Yahoo
Apyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth Conference
2026-07-28 12:00 · Yahoo
Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026
2026-07-23 12:00 · Yahoo
Apyx Medical Corporation (APYX): a High Growth Micro-Cap Stock Improving Cellulite and Skin laxity
2026-06-19 18:21 · Yahoo
How The Apyx Medical (APYX) Story Is Shifting With AYON, GLP 1 Demand And 2026 Goals
2026-06-01 14:05 · Yahoo
Body by Apyx Takes Center Stage at Miami Swim Week Showcasing Real Patient Transformations and Confidence on the Runway
2026-05-27 12:00 · Yahoo
New Study Shows Significant Improvement in Cellulite and Skin Laxity with Advanced Minimally Invasive Treatment Utilizing Avéli® and Renuvion®
2026-05-21 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.